GlassScriptPhysician profile
Rajeev K Valvani
NPI 1699914564
$1,973.66
in general payments reported to CMS, 2019-2025
10 companies · $1,204 in 2025
The $1,204 reported for 2025 was more than what 89% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $11.91 · 2021: $69.17 · 2022: $161 · 2023: $180 · 2024: $192 · 2025: $1,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $901 · Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $900.72 |
| Food and Beverage | $675.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $957.06 | 2025 | Optablate |
| Ferring Pharmaceuticals INC. | $728.86 | 2019-2025 | Euflexxa |
| Abbott Laboratories | $125.09 | 2019 | |
| Bioventus LLC | $67.50 | 2024-2025 | Durolane, Gelsyn-3 |
| Ermi LLC | $18.45 | 2024 | |
| Biotronik Nro, INC. | $17.82 | 2024 | Prospera |
| Avanos Medical | $16.34 | 2023 | Trivisc Sodium Hyaluronate |
| Bard Peripheral Vascular, INC. | $15.59 | 2025 | Venclose Maven Catheter |
| Janssen Pharmaceuticals, INC | $15.04 | 2019 | |
| Pacira Therapeutics, INC. | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Valvani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.